_id
6915e73bbc934aba376b1ae4
Ticker
PROT
Name
Proteonomix Inc
Exchange
OTCCE
Address
145 Highview Terrace, Hawthorne, NJ, United States, 07506
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.proteonomix.com
Description
Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company's products include Proteoderm, an anti-aging skin cream based on a proprietary and patented matrix of proteins that reduce wrinkles; UMK-121, a treatment for liver disease using a combination of two or three approved drugs to mobilize particular bone marrow stem cells; and StromaCel, a treatment for cardiac patients within two weeks of a myocardial infarction using stem cells derived from donor bone marrow and administered through IV solution to repair heart tissue. Its products also comprise NC-138, a proprietary matrix of proteins, which act on the skin to enhance activities that reduce wrinkles. The company was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. Proteonomix, Inc. was incorporated in 1995 and is based in Hawthorne, New Jersey.
Last Close
0.0001
Volume
-
Current Price
0.0001
Change
0
Last Updated
2026-01-06T09:33:23.266Z
Image
-
Ipo Date
-
Market Cap
791
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2012-06-30
Revenue
0
Cost Of Revenue
0
Gross Profit
0
Operating Expenses
757654
Operating Income
-757654
Interest Expense
13977
Pretax Income
1433144
Net Income
1443568
Eps
-
Dividends Per Share
0
Shares Outstanding
7910556
Income Tax Expense
0
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
2190798
Cash
2398357
Short Term Investments
0
Receivables
0
Inventories
0
Total Current Assets
2783357
Property Plant Equipment
31885
Total Assets
5754253
Payables
1538581
Short Term Debt
0
Long Term Debt
0
Total Liabilities
5755340
Equity
-1685
Bs_currency_symbol
USD
Depreciation
734.44
Change In Working Capital
-
Cash From Operations
-4368.56
Capital Expenditures
98.23
Cash From Investing
-268.28
Cash From Financing
-1600.62
Net Change In Cash
-6223.81
Cf_currency_symbol
USD
PE
-
PB
0
ROE
-85671.69139465874
ROA
25.086974799335376
FCF
-4466.79
Fcf Percent
-
Piotroski FScore
1
Health Score
40
Deep Value Investing Score
3
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
4
Net Net Investing Score
2
Quality Investing Score
3
Value Investing Score
1.5
Quarters > 0 > quarter
2012-06-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
0
Quarters > 0 > income Statement > gross Profit
0
Quarters > 0 > income Statement > operating Expenses
757654
Quarters > 0 > income Statement > operating Income
-757654
Quarters > 0 > income Statement > interest Expense
13977
Quarters > 0 > income Statement > pretax Income
1433144
Quarters > 0 > income Statement > net Income
1443568
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
0
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
2190798
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
2398357
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
0
Quarters > 0 > balance Sheet > inventories
0
Quarters > 0 > balance Sheet > total Current Assets
2783357
Quarters > 0 > balance Sheet > property Plant Equipment
31885
Quarters > 0 > balance Sheet > total Assets
5754253
Quarters > 0 > balance Sheet > payables
1538581
Quarters > 0 > balance Sheet > short Term Debt
0
Quarters > 0 > balance Sheet > long Term Debt
0
Quarters > 0 > balance Sheet > total Liabilities
5755340
Quarters > 0 > balance Sheet > equity
-1685
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
1443568
Quarters > 0 > cash Flow > depreciation
734.44
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-4368.56
Quarters > 0 > cash Flow > capital Expenditures
98.23
Quarters > 0 > cash Flow > cash From Investing
-268.28
Quarters > 0 > cash Flow > cash From Financing
-1600.62
Quarters > 0 > cash Flow > net Change In Cash
-6223.81
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
0
Quarters > 0 > ratios > ROE
-85671.69139465874
Quarters > 0 > ratios > ROA
25.086974799335376
Quarters > 0 > ratios > FCF
-4466.79
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
40
Quarters > 1 > quarter
2012-03-31
Quarters > 1 > income Statement > revenue
2290
Quarters > 1 > income Statement > cost Of Revenue
585
Quarters > 1 > income Statement > gross Profit
1705
Quarters > 1 > income Statement > operating Expenses
2219470
Quarters > 1 > income Statement > operating Income
-2217180
Quarters > 1 > income Statement > interest Expense
18825
Quarters > 1 > income Statement > pretax Income
-2192193
Quarters > 1 > income Statement > net Income
-2192193
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
0
Quarters > 1 > income Statement > shares Outstanding
0
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-96820.08733624454
Quarters > 1 > income Statement > total Other Income Expense Net
24987
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
3199455
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
20763
Quarters > 1 > balance Sheet > inventories
190905
Quarters > 1 > balance Sheet > total Current Assets
3967123
Quarters > 1 > balance Sheet > property Plant Equipment
20773
Quarters > 1 > balance Sheet > total Assets
6997996
Quarters > 1 > balance Sheet > payables
881445
Quarters > 1 > balance Sheet > short Term Debt
0
Quarters > 1 > balance Sheet > long Term Debt
0
Quarters > 1 > balance Sheet > total Liabilities
6641346
Quarters > 1 > balance Sheet > equity
356052
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-2192193
Quarters > 1 > cash Flow > depreciation
94582
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-503207
Quarters > 1 > cash Flow > capital Expenditures
248.97
Quarters > 1 > cash Flow > cash From Investing
-14717
Quarters > 1 > cash Flow > cash From Financing
3717366
Quarters > 1 > cash Flow > net Change In Cash
3199442
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
0
Quarters > 1 > ratios > ROE
-615.69461764012
Quarters > 1 > ratios > ROA
-31.326011046591052
Quarters > 1 > ratios > FCF
-503455.97
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-219.84976855895195
Quarters > 1 > health Score
14
Quarters > 2 > quarter
2011-12-31
Quarters > 2 > income Statement > revenue
7010
Quarters > 2 > income Statement > cost Of Revenue
-38434
Quarters > 2 > income Statement > gross Profit
45444
Quarters > 2 > income Statement > operating Expenses
400416
Quarters > 2 > income Statement > operating Income
-393406
Quarters > 2 > income Statement > interest Expense
16908
Quarters > 2 > income Statement > pretax Income
-410314
Quarters > 2 > income Statement > net Income
-410314
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
0
Quarters > 2 > income Statement > shares Outstanding
0
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-5612.06847360913
Quarters > 2 > income Statement > total Other Income Expense Net
-16908
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
13
Quarters > 2 > balance Sheet > short Term Investments
0
Quarters > 2 > balance Sheet > receivables
20763
Quarters > 2 > balance Sheet > inventories
191490
Quarters > 2 > balance Sheet > total Current Assets
230266
Quarters > 2 > balance Sheet > property Plant Equipment
22779
Quarters > 2 > balance Sheet > total Assets
3341004
Quarters > 2 > balance Sheet > payables
1013808
Quarters > 2 > balance Sheet > short Term Debt
0
Quarters > 2 > balance Sheet > long Term Debt
0
Quarters > 2 > balance Sheet > total Liabilities
7038600
Quarters > 2 > balance Sheet > equity
-3697846
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-410314
Quarters > 2 > cash Flow > depreciation
92395
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-136631
Quarters > 2 > cash Flow > capital Expenditures
166.06
Quarters > 2 > cash Flow > cash From Investing
-28770
Quarters > 2 > cash Flow > cash From Financing
165409
Quarters > 2 > cash Flow > net Change In Cash
8
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
0
Quarters > 2 > ratios > ROE
11.096027254785625
Quarters > 2 > ratios > ROA
-12.281158597834663
Quarters > 2 > ratios > FCF
-136797.06
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-19.514559201141225
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2011-09-30
Quarters > 3 > income Statement > revenue
7015
Quarters > 3 > income Statement > cost Of Revenue
30760
Quarters > 3 > income Statement > gross Profit
-23745
Quarters > 3 > income Statement > operating Expenses
385997
Quarters > 3 > income Statement > operating Income
-378982
Quarters > 3 > income Statement > interest Expense
20880
Quarters > 3 > income Statement > pretax Income
-399862
Quarters > 3 > income Statement > net Income
-399862
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
0
Quarters > 3 > income Statement > shares Outstanding
0
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-5402.451888809694
Quarters > 3 > income Statement > total Other Income Expense Net
-20880
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
5
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
19282
Quarters > 3 > balance Sheet > inventories
153056
Quarters > 3 > balance Sheet > total Current Assets
202343
Quarters > 3 > balance Sheet > property Plant Equipment
25066
Quarters > 3 > balance Sheet > total Assets
3376707
Quarters > 3 > balance Sheet > payables
900242
Quarters > 3 > balance Sheet > short Term Debt
0
Quarters > 3 > balance Sheet > long Term Debt
0
Quarters > 3 > balance Sheet > total Liabilities
6935989
Quarters > 3 > balance Sheet > equity
-3559532
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-399862
Quarters > 3 > cash Flow > depreciation
95378
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-68402
Quarters > 3 > cash Flow > capital Expenditures
287.78
Quarters > 3 > cash Flow > cash From Investing
-28770
Quarters > 3 > cash Flow > cash From Financing
67893
Quarters > 3 > cash Flow > net Change In Cash
-509
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
0
Quarters > 3 > ratios > ROE
11.233555422454412
Quarters > 3 > ratios > ROA
-11.84177365699778
Quarters > 3 > ratios > FCF
-68689.78
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-9.79184319315752
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2011-12-31
Annuals > 0 > income Statement > revenue
26004
Annuals > 0 > income Statement > cost Of Revenue
-513
Annuals > 0 > income Statement > gross Profit
26517
Annuals > 0 > income Statement > operating Expenses
1333153
Annuals > 0 > income Statement > operating Income
-1307149
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-1383792
Annuals > 0 > income Statement > net Income
-1383846
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
0
Annuals > 0 > income Statement > income Tax Expense
54
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-5026.722811875096
Annuals > 0 > income Statement > total Other Income Expense Net
-76643
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
13
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
20763
Annuals > 0 > balance Sheet > inventories
191490
Annuals > 0 > balance Sheet > total Current Assets
230266
Annuals > 0 > balance Sheet > property Plant Equipment
22779
Annuals > 0 > balance Sheet > total Assets
3341004
Annuals > 0 > balance Sheet > payables
1013808
Annuals > 0 > balance Sheet > short Term Debt
0
Annuals > 0 > balance Sheet > long Term Debt
0
Annuals > 0 > balance Sheet > total Liabilities
7038600
Annuals > 0 > balance Sheet > equity
-3697846
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-1383846
Annuals > 0 > cash Flow > depreciation
377057
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-277210
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-38330
Annuals > 0 > cash Flow > cash From Financing
315535
Annuals > 0 > cash Flow > net Change In Cash
-5
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
0
Annuals > 0 > ratios > ROE
37.42302951502037
Annuals > 0 > ratios > ROA
-41.42006414838175
Annuals > 0 > ratios > FCF
-277210
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-10.66028303337948
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2010-12-31
Annuals > 1 > income Statement > revenue
83321
Annuals > 1 > income Statement > cost Of Revenue
15850
Annuals > 1 > income Statement > gross Profit
67471
Annuals > 1 > income Statement > operating Expenses
3533392
Annuals > 1 > income Statement > operating Income
-3450071
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-3469097
Annuals > 1 > income Statement > net Income
-3470035
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
0
Annuals > 1 > income Statement > income Tax Expense
938
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-4140.698023307449
Annuals > 1 > income Statement > total Other Income Expense Net
-19026
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
18
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
15379
Annuals > 1 > balance Sheet > inventories
187299
Annuals > 1 > balance Sheet > total Current Assets
202696
Annuals > 1 > balance Sheet > property Plant Equipment
31928
Annuals > 1 > balance Sheet > total Assets
3652161
Annuals > 1 > balance Sheet > payables
2952590
Annuals > 1 > balance Sheet > short Term Debt
0
Annuals > 1 > balance Sheet > long Term Debt
0
Annuals > 1 > balance Sheet > total Liabilities
7095011
Annuals > 1 > balance Sheet > equity
-3443100
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-3470035
Annuals > 1 > cash Flow > depreciation
244607
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-565334
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-215265
Annuals > 1 > cash Flow > cash From Financing
680790
Annuals > 1 > cash Flow > net Change In Cash
-99809
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
0
Annuals > 1 > ratios > ROE
100.78228921611338
Annuals > 1 > ratios > ROA
-95.01319903476325
Annuals > 1 > ratios > FCF
-565334
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-6.785012181802907
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2009-12-31
Annuals > 2 > income Statement > revenue
141647
Annuals > 2 > income Statement > cost Of Revenue
23192
Annuals > 2 > income Statement > gross Profit
118455
Annuals > 2 > income Statement > operating Expenses
3960391
Annuals > 2 > income Statement > operating Income
-3818744
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-3858012
Annuals > 2 > income Statement > net Income
-3858012
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
0
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-2695.958262441139
Annuals > 2 > income Statement > total Other Income Expense Net
-39268
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
99827
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
41813
Annuals > 2 > balance Sheet > inventories
192465
Annuals > 2 > balance Sheet > total Current Assets
334105
Annuals > 2 > balance Sheet > property Plant Equipment
41077
Annuals > 2 > balance Sheet > total Assets
411021
Annuals > 2 > balance Sheet > payables
2359116
Annuals > 2 > balance Sheet > short Term Debt
0
Annuals > 2 > balance Sheet > long Term Debt
0
Annuals > 2 > balance Sheet > total Liabilities
4903028
Annuals > 2 > balance Sheet > equity
-4492257
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-3858012
Annuals > 2 > cash Flow > depreciation
13906
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-205796
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-215265
Annuals > 2 > cash Flow > cash From Financing
305508
Annuals > 2 > cash Flow > net Change In Cash
99712
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
0
Annuals > 2 > ratios > ROE
85.88137321618065
Annuals > 2 > ratios > ROA
-938.6410913310998
Annuals > 2 > ratios > FCF
-205796
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.4528793408967362
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2008-12-31
Annuals > 3 > income Statement > revenue
132038
Annuals > 3 > income Statement > cost Of Revenue
17511
Annuals > 3 > income Statement > gross Profit
114527
Annuals > 3 > income Statement > operating Expenses
4988043
Annuals > 3 > income Statement > operating Income
-4856005
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-4969436
Annuals > 3 > income Statement > net Income
-4969436
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
0
Annuals > 3 > income Statement > income Tax Expense
0
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-3677.732925369969
Annuals > 3 > income Statement > total Other Income Expense Net
-113431
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
115
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
137435
Annuals > 3 > balance Sheet > inventories
191775
Annuals > 3 > balance Sheet > total Current Assets
329325
Annuals > 3 > balance Sheet > property Plant Equipment
50226
Annuals > 3 > balance Sheet > total Assets
420147
Annuals > 3 > balance Sheet > payables
1629373
Annuals > 3 > balance Sheet > short Term Debt
0
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
7843607
Annuals > 3 > balance Sheet > equity
-7423460
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-4969436
Annuals > 3 > cash Flow > depreciation
13906
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-111415
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-215265
Annuals > 3 > cash Flow > cash From Financing
111530
Annuals > 3 > cash Flow > net Change In Cash
115
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
0
Annuals > 3 > ratios > ROE
66.94231530849495
Annuals > 3 > ratios > ROA
-1182.7850728435524
Annuals > 3 > ratios > FCF
-111415
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.8438101152698465
Annuals > 3 > health Score
30
Valuation > metrics > PB
0
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
-85671.69139465874
Profitability > metrics > ROA
51.86427756123271
Profitability > final Score
45
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-54.207197538813766
Risk > final Score
-187
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.8090415779214744
Liquidity > metrics > Quick Ratio
1.8090415779214744
Liquidity > final Score
95
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
0
Prev Profitabilities > 1
22
Prev Profitabilities > 2
22
Prev Risks > 0
-465
Prev Risks > 1
-63
Prev Risks > 2
-43
Prev Liquidities > 0
100
Prev Liquidities > 1
12
Prev Liquidities > 2
13
Updated At
2026-01-20T22:25:37.388Z
Earnings History > 0 > period
2012-03-31
Earnings History > 0 > report Date
2012-06-30
Earnings History > 0 > date
2012-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
0.1817
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0.1817
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2011-12-31
Earnings History > 1 > report Date
2012-03-31
Earnings History > 1 > date
2011-12-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.2808
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.2808
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2011-09-30
Earnings History > 2 > report Date
2011-12-31
Earnings History > 2 > date
2011-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0531
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.0531
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2011-06-30
Earnings History > 3 > report Date
2011-09-30
Earnings History > 3 > date
2011-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.059
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.059
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2011-03-31
Earnings History > 4 > report Date
2011-06-30
Earnings History > 4 > date
2011-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0411
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.0411
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2010-12-31
Earnings History > 5 > report Date
2011-03-31
Earnings History > 5 > date
2010-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.06
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.06
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2010-09-30
Earnings History > 6 > report Date
2010-12-31
Earnings History > 6 > date
2010-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.2342
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.2342
Earnings History > 6 > surprise Percent
-
Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company's products include Proteoderm, an anti-aging skin cream based on a proprietary and patented matrix of proteins that reduce wrinkles; UMK-121, a treatment for liver disease using a combination of two or three approved drugs to mobilize particular bone marrow stem cells; and StromaCel, a treatment for cardiac patients within two weeks of a myocardial infarction using stem cells derived from donor bone marrow and administered through IV solution to repair heart tissue. Its products also comprise NC-138, a proprietary matrix of proteins, which act on the skin to enhance activities that reduce wrinkles. The company was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. Proteonomix, Inc. was incorporated in 1995 and is based in Hawthorne, New Jersey.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ASmall Tire Pro Stock Secures Six Races For Highly Anticipated Second Season - Drag Illustrated
1/20/2026
Small Tire Pro Stock Secures Six Races For Highly Anticipated Second Season Drag Illustrated
Read more →Reigning NHRA Pro Stock Champion Dallas Glenn Set to Make Pro Mod Debut at U.S. Street Nationals Drag Illustrated
Read more →Showing 2 of 10
(Last Updated 2012-06-30)
Health Score
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Proteonomix Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2012-03-31
EPS Actual
0.1817
EPS Estimate
0
EPS Difference
0.1817
Surprise Percent
0%
(Last Updated 2012-06-30)
(Last Updated 2012-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2012-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2012-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.